Acumen Pharmaceuticals' CFO Buys, Sells Shares Amid Market Volatility.
ByAinvest
Wednesday, Jan 28, 2026 7:54 pm ET1min read
ABOS--
Acumen Pharmaceuticals, Inc. (ABOS) has announced that Chief Legal Officer and Corporate Secretary Derek M. Meisner has made recent transactions involving the company's shares. On January 26, 2026, Mr. Meisner purchased 15,085 shares at a price of $1.85 per share, but then sold the same number of shares at a price of $3 per share on the same day. Similarly, on January 28, 2026, Mr. Meisner bought 2,671 shares at $1.85 per share, only to sell them again at $3 per share on the same day.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet